1. Home
  2. CLSD vs GAME Comparison

CLSD vs GAME Comparison

Compare CLSD & GAME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLSD
  • GAME
  • Stock Information
  • Founded
  • CLSD 2011
  • GAME 2011
  • Country
  • CLSD United States
  • GAME United States
  • Employees
  • CLSD N/A
  • GAME N/A
  • Industry
  • CLSD Biotechnology: Pharmaceutical Preparations
  • GAME
  • Sector
  • CLSD Health Care
  • GAME
  • Exchange
  • CLSD Nasdaq
  • GAME Nasdaq
  • Market Cap
  • CLSD 68.4M
  • GAME 66.6M
  • IPO Year
  • CLSD 2016
  • GAME 2009
  • Fundamental
  • Price
  • CLSD $4.37
  • GAME $0.84
  • Analyst Decision
  • CLSD Hold
  • GAME Strong Buy
  • Analyst Count
  • CLSD 4
  • GAME 2
  • Target Price
  • CLSD $65.00
  • GAME $3.00
  • AVG Volume (30 Days)
  • CLSD 78.5K
  • GAME 3.1M
  • Earning Date
  • CLSD 11-11-2025
  • GAME 11-13-2025
  • Dividend Yield
  • CLSD N/A
  • GAME N/A
  • EPS Growth
  • CLSD N/A
  • GAME N/A
  • EPS
  • CLSD N/A
  • GAME N/A
  • Revenue
  • CLSD $4,166,000.00
  • GAME $93,375,339.00
  • Revenue This Year
  • CLSD $98.20
  • GAME $2.32
  • Revenue Next Year
  • CLSD $213.77
  • GAME $26.42
  • P/E Ratio
  • CLSD N/A
  • GAME N/A
  • Revenue Growth
  • CLSD N/A
  • GAME 54.19
  • 52 Week Low
  • CLSD $3.32
  • GAME $0.50
  • 52 Week High
  • CLSD $24.75
  • GAME $2.87
  • Technical
  • Relative Strength Index (RSI)
  • CLSD 45.81
  • GAME 60.18
  • Support Level
  • CLSD $4.00
  • GAME $0.66
  • Resistance Level
  • CLSD $4.45
  • GAME $0.74
  • Average True Range (ATR)
  • CLSD 0.40
  • GAME 0.05
  • MACD
  • CLSD 0.13
  • GAME 0.02
  • Stochastic Oscillator
  • CLSD 83.87
  • GAME 95.35

About CLSD Clearside Biomedical Inc.

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.

About GAME GameSquare Holdings Inc.

GameSquare Holdings Inc is engaged in revolutionizing the way brands and game publishers connect with hard-to-reach Gen Z, Gen Alpha, and Millennial audiences. It's next generation media, entertainment, and technology helps creators and maximize their brand partners' return on investment. Its purpose-built platform provides marketing and creative services, offers data and analytics solutions, and amplifies awareness through FaZe Clan.

Share on Social Networks: